POLY(ADP-RIBOSE) POLYMERASE (PARP) INHIBITION COUNTERACTS MULTIPLE MANIFESTATIONS OF KIDNEY DISEASE IN LONG-TERM STREPTOZOTOCIN-DIABETIC RAT MODEL

Evidence for the important role for poly(ADP-ribose) polymerase (PARP) in the pathogenesis of diabetic nephropathy is emerging. We previously reported that PARP inhibitors counteract early Type 1 diabetic nephropathy. This study evaluated the role for PARP in kidney disease in long-term Type 1 diabe...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biochem Pharmacol
Autors principals: Shevalye, Hanna, Stavniichuk, Roman, Xu, Weizheng, Zhang, Jie, Lupachyk, Sergey, Maksimchyk, Yury, Drel, Viktor R., Floyd, Elizabeth Z., Slusher, Barbara, Obrosova, Irina G.
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4259265/
https://ncbi.nlm.nih.gov/pubmed/19945439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2009.11.018
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars